©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2013; 19(27): 4344-4350
Published online Jul 21, 2013. doi: 10.3748/wjg.v19.i27.4344
Published online Jul 21, 2013. doi: 10.3748/wjg.v19.i27.4344
Table 2 Determinants of adherence in Crohn's disease and rheumatoid arthritis
| Studies on Crohn's disease | Studies on rheumatoid arthritis | ||||
| Kane et al[7] | Billioud et al[17] | Kane et al[18] | Borah et al[19] | Li et al[21] | |
| Female gender | OR < 1 | OR < 1; P < 0.05 | OR < 1 | ||
| Increasing age | OR < 1 | OR > 1 | |||
| Immunomodulator use | OR > 1 | OR < 1 | OR > 1; P < 0.051 | ||
| Prior biologic use | OR < 1; P < 0.05 | OR > 1; P < 0.05 | |||
| Increasing duration of therapy | OR < 1; P < 0.05 | ||||
| Increasing disease duration | OR > 1; P < 0.05 | ||||
- Citation: Fidder HH, Singendonk MM, van der Have M, Oldenburg B, van Oijen MG. Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn’s disease and rheumatoid arthritis: Results of a systematic review. World J Gastroenterol 2013; 19(27): 4344-4350
- URL: https://www.wjgnet.com/1007-9327/full/v19/i27/4344.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i27.4344